Search

Displaying results 6891 - 6900 of 9325 in total
  1. Drug

    TO-901317

    go.drugbank.com/drugs/DB07080
    Experimental

    TO-901317 is an LXRalpha and LXRbeta agonist.

  2. Drug

    MLN3897

    go.drugbank.com/drugs/DB06505
    Experimental

    MLN3897, a novel CCR1 inhibitor, disrupts osteoclast formation and blocks the interaction between multiple myeloma cells and osteoclasts.

    Synonyms: (4S)-4-(4-CHLOROPHENYL)-1-((3E)-3-(9-(1-HYDROXY-1-METHYL-ETHYL)-5H-(1)BENZOXEPINO(3,4-B)PYRIDIN-11-YLIDENE)PROPYL)-3,3-DIMETHYL-PIPERIDIN-4-OL
  3. Drug

    Vamifeport

    go.drugbank.com/drugs/DB17692
    Investigational

    Vamifeport is being investigated for the treatment of beta-thalassemia.

  4. Drug

    Bapineuzumab

    go.drugbank.com/drugs/DB11715
    Investigational

    Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.

  5. Drug

    Pefcalcitol

    go.drugbank.com/drugs/DB11786
    Investigational

    Pefcalcitol has been investigated for the basic science of Psoriasis.

  6. Drug

    Epelsiban

    go.drugbank.com/drugs/DB11934
    Investigational

    Epelsiban has been investigated for the treatment of Premature Ejaculation.

  7. Drug

    Visilizumab

    go.drugbank.com/drugs/DB12053
    Investigational

    Visilizumab has been investigated for the treatment of Ulcerative Colitis.

  8. Drug

    PG-701

    go.drugbank.com/drugs/DB12252
    Investigational

    Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.

  9. Drug

    Nitroaspirin

    go.drugbank.com/drugs/DB12445
    Investigational

    Nitroaspirin has been investigated for the treatment of Intermittent Claudication.

  10. Drug

    Mavrilimumab

    go.drugbank.com/drugs/DB12534
    Investigational

    Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.